1.495
Precedente Chiudi:
$1.48
Aprire:
$1.44
Volume 24 ore:
966
Relative Volume:
0.05
Capitalizzazione di mercato:
$31.56M
Reddito:
$278.00K
Utile/perdita netta:
$-21.06M
Rapporto P/E:
-1.2366
EPS:
-1.209
Flusso di cassa netto:
$-26.80M
1 W Prestazione:
+6.79%
1M Prestazione:
-4.17%
6M Prestazione:
-6.56%
1 anno Prestazione:
-34.72%
Envoy Medical Inc Stock (COCH) Company Profile
Nome
Envoy Medical Inc
Settore
Industria
Telefono
651-361-8000
Indirizzo
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Confronta COCH con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
COCH
Envoy Medical Inc
|
1.44 | 31.56M | 278.00K | -21.06M | -26.80M | -1.209 |
![]()
ABT
Abbott Laboratories
|
134.80 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
106.65 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
394.29 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
86.03 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.60 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-06-24 | Iniziato | Ascendiant Capital Markets | Buy |
Envoy Medical Inc Borsa (COCH) Ultime notizie
Cochlear Implants Industry Growth: Price Advantage & FDA - openPR.com
Life Sciences Investor Forum: Now Available for Online Viewing - The Manila Times
Citadel Advisors LLC Purchases Shares of 10,069 Lavoro Limited (NASDAQ:LVRO) - Defense World
Robinhood Markets, Inc. Reports May 2025 Operating Data - The Manila Times
Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th - GlobeNewswire
Insider Buying: Mona Patel Acquires 10,000 Shares of Envoy Medical Inc (COCH) - GuruFocus
Life Sciences Investor Forum Agenda Announced for June 11th-12th - GlobeNewswire
Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up - Newsfile
Hereditary Deafness Market Booming Worldwide with - openPR.com
“Intel Foundry Will Need to Earn (Intel’s) Business”: Intel Stock (NASDAQ:INTC) Slips as Intel Looks for Better Deal Than Intel - The Globe and Mail
No normal is the new normal - The Globe and Mail
Robinhood Markets Hits 52-Week High: Should You Buy the Stock Now? - The Globe and Mail
Ascendiant Keeps Their Buy Rating on Verb Technology Company (VERB) - The Globe and Mail
Banzai International (BNZI) Gets a Buy from Ascendiant - The Globe and Mail
Cingulate (NASDAQ:CING) Price Target Raised to $61.00 at Ascendiant Capital Markets - Defense World
Unity Biotechnology (NASDAQ:UBX) Receives Neutral Rating from HC Wainwright - Defense World
Blue Bird (NASDAQ:BLBD) Receives Buy Rating from Needham & Company LLC - Defense World
Cognition Therapeutics (NASDAQ:CGTX) Price Target Cut to $3.00 by Analysts at HC Wainwright - Defense World
Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews
Envoy Medical (NASDAQ:COCH) Price Target Raised to $9.50 at Ascendiant Capital Markets - Defense World
Insider Buying: Charles Brynelsen Acquires 50,000 Shares of Envo - GuruFocus
Insider Buying: Charles Brynelsen Acquires 50,000 Shares of Envoy Medical Inc (COCH) - GuruFocus
Envoy Medical Director Charles Brynelsen Acquires 50,000 Shares - TradingView
Envoy Medical (COCH) Maintains Buy Rating as Ascendiant Capital Raises Price Target | COCH Stock News - GuruFocus
Buying Nvidia Stock Before May 28 Could Be Your Last Chance to Get This Magnificent Artificial Intelligence (AI) Stock on the Cheap - The Globe and Mail
Great News for SoFi Stock Investors! - The Globe and Mail
Cochlear Implants Market Projected to Witness Massive Growth in Hearing Loss Treatment Innovations - openPR.com
Sensorineural Hearing Loss Market Set to Grow Substantially - openPR.com
Sensorineural Hearing Loss Market Set to Grow Substantially Through 2032, DelveInsight Projects | Audion Therapeutics, Frequency Therapeutics - The Globe and Mail
Turbulence for Joby Shares: What's Behind the Recent Dip? - The Globe and Mail
23andMe Stock Soars 127% after Regeneron Buys Its Bankrupt DNA Vault - The Globe and Mail
Envoy Medical announces CFO departure By Investing.com - Investing.com South Africa
Envoy Medical announces CFO departure - Investing.com
2 Monthly Dividend Stocks That Are Income Investors' Dreams Right Now - The Globe and Mail
PayPal vs. Block: Which Fintech Stock is a Stronger Buy Right Now? - The Globe and Mail
Envoy Medical advances in cochlear implant trial - Investing.com
Envoy Medical advances in cochlear implant trial By Investing.com - Investing.com Nigeria
Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial - TradingView
Envoy Medical (COCH) Gets a Buy from Lake Street - The Globe and Mail
Envoy Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Envoy Medical Reports on First Quarter 2025 Results - TradingView
Envoy Medical, Inc. SEC 10-Q Report - TradingView
Envoy Medical's Revolutionary Fully Implanted Cochlear Implant Shows Promise in Latest Clinical Trial Data - Stock Titan
Better Dividend Stock: JPMorgan Chase vs. Goldman Sachs - The Globe and Mail
ManpowerGroup Inc. (NYSE:MAN) Receives Consensus Rating of “Hold” from Brokerages - Defense World
Goosehead Insurance (NASDAQ:GSHD) Shares Gap Down After Analyst Downgrade - Defense World
The Campbell’s Company (NASDAQ:CPB) Given Average Rating of “Reduce” by Brokerages - Defense World
Applied Materials, Inc. (NASDAQ:AMAT) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
MarketAxess Holdings Inc. (NASDAQ:MKTX) Given Average Rating of “Hold” by Brokerages - Defense World
IDACORP, Inc. (NYSE:IDA) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Darling Ingredients (NYSE:DAR) Shares Gap Down Following Weak Earnings - Defense World
Envoy Medical Inc Azioni (COCH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Envoy Medical Inc Azioni (COCH) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Patel Mona Chetan | Director |
Jun 06 '25 |
Buy |
1.46 |
10,000 |
14,600 |
17,500 |
BRYNELSEN CHARLES | Director |
May 27 '25 |
Buy |
1.65 |
35,000 |
57,673 |
50,000 |
BRYNELSEN CHARLES | Director |
May 23 '25 |
Buy |
1.64 |
13,000 |
21,363 |
15,000 |
BRYNELSEN CHARLES | Director |
May 22 '25 |
Buy |
1.68 |
2,000 |
3,367 |
2,000 |
Patel Mona Chetan | Director |
Nov 20 '24 |
Buy |
2.28 |
2,500 |
5,699 |
7,500 |
Patel Mona Chetan | Director |
Sep 11 '24 |
Buy |
3.33 |
4,000 |
13,320 |
5,000 |
Patel Mona Chetan | Director |
Sep 09 '24 |
Buy |
3.20 |
1,000 |
3,200 |
1,000 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):